. (2004). Incidence of fatigue symptoms and diagnoses presenting in UK primary care from 1990 to 2001. J R Soc Med. http://doi.org/10.1258/jrsm.97.12.571
A. Gallagher
First name
A.
Middle name
M.
Last name
Gallagher
. (2005). The prognosis of different fatigue diagnostic labels: a longitudinal survey. Fam Pract. http://doi.org/10.1093/fampra/cmi021
. (2008). Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?. J Thromb Haemost. http://doi.org/10.1111/j.1538-7836.2008.03059.x
. (2008). Fracture outcomes related to persistence and compliance with oral bisphosphonates. J Bone Miner Res. http://doi.org/10.1359/jbmr.080510
. (2009). Utilization characteristics and treatment persistence in patients prescribed low-dose buprenorphine patches in primary care in the United Kingdom: a retrospective cohort study. Clin Ther. http://doi.org/10.1016/j.clinthera.2009.08.022
. (2009). Risk markers for both chronic fatigue and irritable bowel syndromes: a prospective case-control study in primary care. Psychol Med. http://doi.org/10.1017/s0033291709005601
. (2009). How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation? An analysis of the UK General Practice Research Database. Thromb Haemost.
. (2011). Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thromb Haemost. http://doi.org/10.1160/th11-05-0353
. (2011). Risk of death and cardiovascular outcomes with thiazolidinediones: a study with the general practice research database and secondary care data. PLoS One. http://doi.org/10.1371/journal.pone.0028157
. (2012). Quality of INR control and outcomes following venous thromboembolism. Clin Appl Thromb Hemost. http://doi.org/10.1177/1076029611426139